406 related articles for article (PubMed ID: 24718088)
1. Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates.
Lee MR; Ko JC; Liang SK; Lee SW; Yen DH; Hsueh PR
Int J Antimicrob Agents; 2014 May; 43(5):438-41. PubMed ID: 24718088
[TBL] [Abstract][Full Text] [Related]
2. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
[TBL] [Abstract][Full Text] [Related]
3. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
5. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary infections caused by a dominant strain of Mycobacterium massiliense (Mycobacterium abscessus subspecies bolletii).
Cheng A; Liu YC; Chen ML; Hung CC; Tsai YT; Sheng WH; Liao CH; Hsueh PR; Chen YC; Chang SC
Clin Microbiol Infect; 2013 Oct; 19(10):E473-82. PubMed ID: 23718188
[TBL] [Abstract][Full Text] [Related]
7.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
8. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
Rubio M; March F; Garrigó M; Moreno C; Español M; Coll P
PLoS One; 2015; 10(10):e0140166. PubMed ID: 26448181
[TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
12.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
[TBL] [Abstract][Full Text] [Related]
14. Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates.
Nie W; Duan H; Huang H; Lu Y; Chu N
Biomed Res Int; 2015; 2015():506598. PubMed ID: 26146620
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
16. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
19. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
20.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
